R. Minami et al., EFFECTS OF ALUMINUM HYDROXIDE AND FAMOTIDINE ON BIOAVAILABILITY OF TOSUFLOXACIN IN HEALTHY-VOLUNTEERS, Antimicrobial agents and chemotherapy, 42(2), 1998, pp. 453-455
This study was designed to determine the influence of aluminum hydroxi
de and famotidine on the bioavailability of tosufloxacin. Coadministra
tion of aluminum hydroxide reduced the bioavailability of tosufloxacin
by 31.6% (P < 0.05). Famotidine did not alter tosufloxacin absorption
. To avoid potential treatment failures, the concurrent use of tosuflo
xacin and aluminum hydroxide should be avoided altogether.